Iron as Preoperative Antituberculosis Supplement Increases Interleukin-12 Level in Spinal Tuberculosis and Iron Deficiency Patients

Anggi Fauziani, Nucki Nursjamsi Hidajat, Ahmad Ramdan

Abstract


Iron deficiency remains the most prevalent micronutrient deficiency worldwide. Iron deficiency in TB patients, causes a poor outcome, reccurency, and treatment failure. Iron supplements on TB patients with iron deficiency will activate macrophage-derived monocytes (MDM) and interferon-gamma (IFN-γ), with a positive feedback mechanism pushing interleukin-12 (IL-12). This study is a single-blind randomized control trial comparing the effectivity of preoperative iron supplementation in IL-12 level between two different groups in Dr. Hasan Sadikin General Hospital Bandung, conducted from November 2018 until March 2019. Respondents are those having Spondylitis TB, with sTfR > 21,7 pg/mL and IL-12 <41 pg/mL, intensive phase antituberculosis drugs category 1. The experimental group, comprised 17 respondents, was treated with 2RHZE and 357mg iron (III) hidroxy polymaltosa. The control group was treated with 2RHZE. The sTfR and IL-12 levels were performed before and after treatment. The increase of IL-12 in the experimental group was +364,53% higher than in the control group (p<0.05). The decrease of sTfR in the experimental group was -60,68% higher than in the control group (p<0.05). The result of the Pearson correlation test was a coefficient correlation of - 0,73, this showed that a decrease in the sTfR level correlated with an increase in the Il-12 level. Iron supplement in Spondylitis TB with iron deficiency in the experimental group increases the IL-12 level. Preoperative iron supplementation on spondylitis TB with iron deficiency, increases the immune system with higher levels of IL-12.


Perbedaan Kadar IL-12 pada Terapi Pre-Operatif Spondilitis TB
dengan Defisiensi Zat Besi yang diberikan Suplementasi Zat Besi

Defisiensi Fe merupakan defisiensi mikronutrien paling sering di seluruh dunia, jika terjadi pada penderita TB akan meningkatkan risiko prognosa buruk, rekurensi, MDR, dan gagal terapi. Suplementasi besi pada tuberkulosa dengan defisiensi besi akan meningkatkan sistem imun dengan mengaktivasi macrophage derived monocyt, dan interferon-gamma, dengan mekanisme umpan balik positif memacu interleukin-12. Single blind randomized control trial untuk membandingkan efektivitas Fe terhadap kenaikan IL-12 pada terapi preoperatif spondilitis TB di RSHS periode Nopember 2018- Maret 2019. Metode sampling;consecutive sampling. Subjek sebanyak 34 orang; Penderita spondilitis TB, sTfR >21,7 pg/ml dan IL-12< 41 pg/mL. fase intensif OAT kategori 1sesuai dengan standar WHO. Kelompok eksperimen, 17responden diterapi 2 RHZE + tablet iron (III) hidroksi polimaltosa357 mg selama 2 bulan. Kelompok kontrol 17 responden diterapi 2RHZE. Peningkatan IL-12 pada kelompok eksperimen sebesar +364,53% lebih besar dari kelompok kontrol (p<0,05) dan; Penurunan kadar sTfR pada kelompok eksperimen sebesar –60,68% (p<0,05) lebih besar dari kontrol. Uji korelasi sTfR dan IL-12 dengan Pearson ; korelasi -0,763, menunjukkan korelasi kuat antara penurunan sTfR dan kenaikan nilai IL-12. Suplementasi Fe pada terapi preoperatif spondilitis TB dengan defisiensi Fe meningkatkan respon imun yang ditandai dengan meningkatnya IL-12.


Keywords


Interleukin-12, iron supplementation, spinal tuberculosis

Full Text:

PDF

References


World Health Organization. Global tuberculosis report. Geneva; 2018.

Isanaka S, Aboud S, Mugusi F, Bosch RJ, Willett WC, Spiegelman D, et al. Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PloS one. 2012;7(5):e37350.

Millet J MA, Fina L, Bano L, Et all. Factors that inluence current tuberculosis epidemiology. Euro Spine J. 2013;22:539–48.

Pellise F. Tuberculosis and Pott's disease, still very relevant health problems. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2013;22(Suppl 4):527–8.

Tuli M. Historical aspects of pott,s disease (spinal tuberculosis) management. Euro J Spine. 2013;22:529–38.

Minchella PA, Donkor S, Owolabi O, Sutherland JS, McDermid JM. Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions. Clin Infect Dis. 2015;60(5):764–72.

Mishra S, Taparia P, Yadav D, Koolwal S. Study of iron metabolism in pulmonary tuberculosis patients. International J Health Sci Res. 2018;8(3):70–7.

Ganz T. Iron in innate immunity: starve and invaders. Curr Opin Immunol. 2009;21(1): 63–7.

Kuvibidila SR, Gardner R, Velez M, Yu L. Iron deficiency, but not underfeeding reduces the secretion of interferon-gamma by mitogen-activated murine spleen cells. Cytokine. 2010;52(3):230–7.

Subagyo DTL, Soeharyo H, Hadiarto M. Pengaruh suplementasi besi pada tuberkulosis (kajian respon kesembuhan, respon imun, dan resistensi). Sains Medika, J Med Health. 2010;2(1):57–69.

Tatar D, Senol G, Alptekin S, Gunes E, Aydin M, Gunes O. Assessment of extrapulmonary tuberculosis in two provinces of Turkey. Iran J Public Health. 2016;45(3):305–13.

Moon MS. Tuberculosis of spine: current views in diagnosis and management. Asian Spine J. 2014;8(1):97–111.

Rajasekaran S, Khandelwal G. Drug therapy in spinal tuberculosis. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2013;22 (Suppl 4):587–93.

Cao G, Rao J, Cai Y, Wang C, Liao W, Chen T, et al. Analysis of treatment and prognosis of 863 patients with spinal tuberculosis in Guizhou Province. Biomed Res Int. 2018;2018:3265735.

Wang B, Kong L, Zhu Z, Gao W, Guo H, Wang X, et al. Recurrent complex spinal tuberculosis accompanied by sinus tract formation: causes of recurrence and clinical treatments. Sci Rep. 2018;8(1):6933.

Froissart A, Rossi B, Ranque B, Jarrin I, Bergmann JF, Beaune S, et al. Effect of a red blood cell transfusion on biological markers used to determine the cause of anemia: a prospective study. Am J Med. 2018;131(3):319–22.

Okam, Maureen M. et al. Iron supplementation, response in iron-deficiency anemia: analysis of five trials. Am J Med, 2017;130(8):991.e1–8.

Minchella PA, Donkor S, Owolabi O, Sutherland JS, McDermid JM. Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions. Clin Infect Dis. 2015;60(5):764–72

Mendez S, Traslavina R, Hinchman M, Huang L, Green P, Cynamon MH, et al. The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells. Antimicrob Agents Chemother. 2009;53(12):5114–21.

de Oliveira LR, Peresi E, Golim Mde A, Gatto M, Araujo Junior JP, da Costa EA, et al. Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment. PloS one. 2014;9(2):e88572.




DOI: https://doi.org/10.15851/jap.v8n1.1965



 

This Journal indexed by

                               


 
Creative Commons License
JAP is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 



View My Stats